Subscribe to RSS
DOI: 10.1055/s-2006-951337
© Georg Thieme Verlag KG Stuttgart · New York
Die systemische Mastzellerkrankung mit gastrointestinal betonter Symptomatik - eine Checkliste als Diagnoseinstrument
Systemic mast cell disease with gastrointestinal symptoms - a diagnostic questionnairePublication History
eingereicht: 10.1.2006
akzeptiert: 3.8.2006
Publication Date:
18 September 2006 (online)

Zusammenfassung
Eine systemische Mastzellerkrankung manifestiert sich unter anderem häufig in Form von episodischen oder chronischen unspezifischen gastrointestinalen Beschwerden. Krankhaft veränderte Mastzellen, die aufgrund genetischer Mutationen eine erhöhte Proliferationsrate und eine Anreicherung in Organen aufweisen, können über ihre Mediatoren sehr effektiv die Sekretion, Absorption, Schmerzperzeption und Motilität des Gastrointestinaltrakts beeinflussen, ohne dass in den routinemäßig untersuchten Laborparametern und bildgebenden Verfahren wesentliche pathologische Veränderungen auffällig werden. In der vorliegenden Arbeit wird aus interdisziplinärerer Sicht dargestellt, wie aus der Gesamtschau der klinischen Befunde mit Hilfe einer Checkliste die Diagnose systemische Mastzellerkrankung gestellt werden kann.
Summary
Systemic mast cell disease often becomes clinically manifest as a mast cell mediator activation syndrome with episodic or chronic nonspecific abdominal symptoms. As a result of genetic alterations, pathological mast cells have an increased proliferation rate as well as accumulation within different organs with consequential effect on gastrointestinal secretion, absorption, pain perception and motility caused by release of their mediators. These changes may not be detected in routine laboratory or imaging methods. This report describes how the diagnosis systemic mast cell disease can be established with a diagnostic questionnaire based on a synopsis of clinical findings relevant to a mast cell mediator activation syndrome.
Schlüsselwörter
systemische Mastzellerkrankung - Mastzellmediatoren - Checkliste
Key words
systemic mast cell disease - mast cell mediators - diagnostic questionnaire
Literatur
- 1
Adler S N, Klein R A, Lyon D T.
Bleeding after liver biopsy in a patient with systemic mastocytosis and malabsorption.
J Clin Gastroenterol.
1985;
7
350-353
MissingFormLabel
- 2
Akin C.
Clonality and molecular pathogenesis of mastocytosis.
Acta haematol.
2005;
114
61-69
MissingFormLabel
- 3
Barbara G, Stanghellini V, De Giorgio R. et al .
Activated mast cells in proximity to colonic nerves correlate with abdominal pain
in irritable bowel syndrome.
Gastroenterology.
2004;
126
693-702
MissingFormLabel
- 4
Crivellato E, Beltrami C A, Mallardi F, Ribatti D.
The mast cell: an active participant or an innocent bystander?.
Histol Histopathol.
2004;
19
259-270
MissingFormLabel
- 5
Delling G, Ritzel H, Werner M.
Histologische Charakteristika und Häufigkeit der sekundären Osteoporose bei systemischer
Mastozytose.
Pathologie.
2001;
22
132-140
MissingFormLabel
- 6
Escribano L, Akin C, Castells M, Schwartz L B.
Current options in the treatment of mast cell mediator-related symptoms in mastocytosis.
Inflamm Allergy Drug Targets.
2006;
5
61-77
MissingFormLabel
- 7
Florian S, Krauth M T, Simonitsch-Klupp I. et al .
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions,
and recurrent severe anaphylactoid episodes.
Int Arch Allergy Immunol.
2005;
136
273-280
MissingFormLabel
- 8
Frieling T, Cooke H J, Wood J D.
Neuroimmune communication in the submucous plexus of guinea pig colon after sensitization
to milk antigen.
Am J Physiol.
1994;
267
G1087-G1093
MissingFormLabel
- 9
Frieling T, Palmer J M, Cooke H J, Wood J D.
Neuroimmune communication in the submucous plexus of guinea pig colon after infection
with Trichinella spiralis.
Gastroenterology.
1994;
107
1602-1609
MissingFormLabel
- 10
Frungieri M B, Weidinger S, Meineke V, Köhn F M, Mayerhofer A.
Proliferative action of mast cell tryptase is mediated by PAR2, COX2, prostaglandins,
and PPAR-gamma: Possible relevance to human fibrotic disorders.
PNAS.
2002;
99
15072-15077
MissingFormLabel
- 11
Henz B M, Maurer M, Lippert U, Worm M, Babina M.
Mast cells as initiators of immunity and host defense.
Exp Dermatol.
2001;
10
1-10
MissingFormLabel
- 12
Horan R F, Austen K F.
Systemic mastocytosis: retrospective review of a decadeŽs clinical experience at the
Brigham and WomenŽs Hospital.
J Invest Dermatol.
1991;
96
5S-14S
MissingFormLabel
- 13
Horny H P, Sotlar K, Sperr W, Valent P.
Systemic mastocytosis with associated clonal haematological non-mast cell lineage
diseases: a histopathological challenge.
J Clin Pathol.
2004;
57
604-608
MissingFormLabel
- 14
Jensen R T.
Gastrointestinal abnormalities and involvement in systemic mastocytosis.
Hematology/Oncology Clinics North America.
2000;
14
579-623
MissingFormLabel
- 15
Jordan J H, Jager E, Sperr W R. et al .
Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential
diagnostic implications and comparison with myeloproliferative disorders.
Eur Clin Invest.
2003;
33
611-618
MissingFormLabel
- 16
Lange U, Teichmann J, Strunk J.
Systemische Mastozytose als Ursache einer Osteoporose.
Akt Rheumatol.
2003;
28
108-112
MissingFormLabel
- 17
Maslinska D, Laure-Kaminiowska M, Gujski M, Ciurzynska G, Wojtecka-Lukasik E.
Post- infectional distribution and phenotype of mast cells penetrating human brains.
Inflamm Res.
2005;
(Suppl 1)
54
15-16
MissingFormLabel
- 18
McKay D M, Bienenstock J.
The interaction between mast cells and nerves in the gastrointestinal tract.
Immunology today.
1994;
15
533-538
MissingFormLabel
- 19
Michel K, Zeller F, Langer R. et al .
Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors.
Gastroenterology.
2005;
128
1317-1326
MissingFormLabel
- 20
Molderings G J.
Physiologische und therapeutische Bedeutung von Serotonin und des serotoninergen Systems.
Arzneim-Forsch/Drug Res.
2002;
52
145-154
MissingFormLabel
- 21
Molderings G J, Homann J, Brüss M.
Episodische gastrointestinale Beschwerden als Facette der systemischen Mastozytose
- Kasuistik und neue Nachweismethode.
Med Welt.
2002;
53
255-260
MissingFormLabel
- 22
Molderings G J, Brüss M, Raithel M. et al .
Systemische Mastozytose als Grund für chronische gastrointestinale Beschwerden.
Dtsch Arztebl.
2005;
102
A1744-A1749
MissingFormLabel
- 23
Park C H, Joo Y E, Choi S K, Rew J S, Kim S J, Lee M C.
Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant
irritabale bowel syndrome.
J Korean Med Sci.
2003;
18
204-210
MissingFormLabel
- 24
Parker R I.
Hematologic aspects of systemic mastocytosis.
Mast Cell Disorders.
2000;
14
557-568
MissingFormLabel
- 25
Rohr S M, Rich M W, Silver K H.
Shortness of breath, syncope, and cardiac arrest caused by systemic mastocytosis.
Ann Emerg Med.
2005;
45
592-594
MissingFormLabel
- 26
Rottem M, Mekori Y A.
Mast cells autoimmunity.
Autoimmunity Rev.
2005;
4
21-27
MissingFormLabel
- 27
Schemann M, Michel K, Ceregrzyn M, Zeller F, Seidl S, Bischoff S C.
Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric
nervous system.
Neurogastroenterol Motil.
2005;
17
281-289
MissingFormLabel
- 28
Shibao C, Arzubiaga C, Roberts L J. et al .
Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders.
Hypertension.
2005;
45
385-390
MissingFormLabel
- 29
Silver R B, Reid A C, Mackins C J. et al .
Mast cells: a unique source of renin.
PNAS.
2004;
101
13607-13612
MissingFormLabel
- 30
Spiller RC.
Postinfectious irritable bowel syndrome.
Gastroenterology.
2003;
124
1662-1671
MissingFormLabel
- 31
Theoharides T C.
The mast cell: a neuroimmunoendocrine master player.
Int J Tiss Reac.
1996;
XVIII
1-21
MissingFormLabel
- 32
Theoharides T C, Donelan J, Kandere-Grzybowska K, Konstantinidou A.
The role of mast cells in migraine pathophysiology.
Brain Res Rev.
2005;
49
65-76
MissingFormLabel
- 33
Thienemann F, Henz B M, Babina M.
Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4
on immature cell lines versus mature human skin mast cells.
Arch Dermatol Res.
2004;
296
134-138
MissingFormLabel
- 34
Valabhij J, Robinson S, Johnson D, Mellamy M, Davies W, Bain B J.
Unexpected loss of consciousness: systemic mastocytosis.
J Royal Soc Med.
2000;
93
141-142
MissingFormLabel
- 35
Valent P, Akin C, Sperr W R. et al .
Diagnosis and treatment of systemic mastocytosis: state of the art.
Br J Haematol.
2003;
122
695-717
MissingFormLabel
- 36
Vliagoftis H, Befus A D.
Rapidly changing perspectives about mast cells at mucosal surfaces.
Immunol Rev.
2005;
206
190-203
MissingFormLabel
- 37
Xu X, Rivkind A, Pappo O, Pikarsky A, Levi-Schaffer F.
Role of mast cells and myofibroblasts in human peritoneal adhesion formation.
Ann Surg.
2002;
236
593-601
MissingFormLabel
Prof. Gerhard J. Molderings
Institut für Pharmakologie und Toxikologie, Universitätsklinikum Bonn
Reuterstraße 2b
53113 Bonn
Phone: 0228/735421
Fax: 0228/735404
Email: molderings@uni-bonn.de